2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Lockheed Martin entered a new $2.25 billion 364-day unsecured revolving credit facility on August 24, 2026, replacing a prior 364-day facility dated December 5, 2025, with no borrowings made at closing. It also extended its existing $3.0 billion 5-year revolving credit agreement by one year, to August 24, 2031. The filing describes committed backup liquidity rather than new debt drawn, and it does not state any change to the company's financial results.
New 364-day revolving credit facility of $2.25 billion, dated August 24, 2026; no borrowings made at closing
Facility matures August 23, 2027, with an option to convert outstanding borrowings into a one-year term loan for a fee of 0.50%
5-year $3.0 billion revolving credit agreement extended from August 24, 2030 to August 24, 2031
Term SOFR margin ranges from 0.585% to 1.085%, based on senior unsecured credit ratings
JBG SMITH Properties LP entered into a Second Amended and Restated Credit Agreement with Bank of America on August 27, 2026, providing a $690.0 million senior unsecured revolver maturing August 27, 2030, with $230.0 million drawn as of that date. The company also amended two Wells Fargo term loans and its $120.0 million 2023 Term Loan to align covenants with the new revolver, extending part of a $400.0 million term loan to August 25, 2028.
$690.0 million revolving facility replaces the $750.0 million Existing Credit Agreement, which was due June 29, 2027; $230.0 million was drawn as of August 27, 2026
Revolver matures August 27, 2030, with two six-month extension options at a 0.075% fee each
$228.9 million of the $400.0 million Tranche A-2 term loan was extended to August 25, 2028; $171.1 million remains due January 13, 2028, and the term loan was increased by $15.0 million
Financial covenants include total indebtedness to property valuation of not more than 60% and EBITDA to fixed charges of at least 1.50 to 1.00
Southern Cross Acquisition II Corp., a blank check company, closed its initial public offering on August 27, 2026, selling 7,652,630 units at $10.00 each for gross proceeds of $76,526,300. About $76,717,616 from the IPO and private unit sale was placed in a trust account, and access to those funds is restricted until a business combination or other specified events occur. The company also appointed three independent directors and adopted amended and restated articles of association.
Closed IPO on August 27, 2026 of 7,652,630 units at $10.00 per unit, including a partial over-allotment of 152,630 units, for gross proceeds of $76,526,300.
Sold 224,932 private units to the Sponsor and D. Boral Capital LLC for $2,249,320.
About $76,717,616 placed in the trust account; funds are not released until a business combination, a shareholder redemption event, or failure to complete a business combination within 12 months.
Hongmei Zhao, Wenhua Qian and Zhiqiang Du became independent directors effective August 26, 2026.
OceanLight Acquisition Corp said underwriters exercised in full their over-allotment option for 1,500,000 additional units, with the closing on August 24, 2026, generating $15,000,000 in gross proceeds. The sponsor also bought 7,500 private placement units for $75,000. The filing says $115,000,000 of IPO net proceeds from the Units, Option Units and Private Placement Units was placed in a trust account.
Underwriters exercised the over-allotment option in full on August 21, 2026, buying 1,500,000 Option Units at $10.00 each; closing occurred August 24, 2026 for $15,000,000 in gross proceeds
OceanLight Capital Sponsor Ltd. bought 7,500 private placement units at $10.00 each, generating $75,000
A total of $115,000,000 ($10.00 per Unit) of net proceeds was placed in a trust account maintained by Continental Stock Transfer & Trust Company
Pro forma public shares subject to redemption rise to 11,500,000 from 10,000,000
Avidbank Holdings sold $30 million of 7.00% fixed-to-floating subordinated notes due September 1, 2036, under an agreement dated August 26, 2026, with institutional purchasers. The company plans to use the proceeds to redeem its $22 million of 5.000% subordinated notes due 2029 and for general corporate purposes, and on August 27, 2026 it repurchased $18 million of those 2029 notes and called the remaining $4 million for September 30, 2026.
$30 million of notes sold at 100% of face amount, fixed at 7.00% until September 1, 2031, then resetting quarterly to three-month term SOFR plus 291 basis points
On August 27, 2026, $18 million of the 2029 notes were repurchased for about $18.2 million, including accrued interest; the remaining $4 million is to be redeemed on September 30, 2026
The notes are unsecured, subordinated obligations, are intended to qualify as Tier 2 regulatory capital, and were sold in a private placement with Piper Sandler & Co. as sole placement agent
Scotts Miracle-Gro's subsidiaries and JPMorgan Chase Bank amended their receivables purchase agreement, extending the facility's purchase termination date from September 1, 2026 to August 31, 2027. The uncommitted facility allows sales of up to $750 million in receivables from five specified customers, and the company says it expects to use the proceeds for general corporate purposes.
Purchase termination date extended from September 1, 2026 to August 31, 2027, under an amendment dated August 24, 2026
Facility allows sale of up to $750 million of receivables from five specified customers on an uncommitted, weekly basis
Recourse obligations are backed by $75 million in standby letters of credit under the company's senior secured revolving facility
Seller continues as servicer for a 20 basis point servicer fee
Perma-Pipe International Holdings entered into a new secured credit agreement with J.P. Morgan on August 25, 2026, replacing its existing credit agreement, which was terminated and repaid in full. The facility includes a $75.0 million revolver and a $14.0 million term loan, with up to $50.0 million of additional capacity available on request, and matures August 25, 2031. The filing describes the change as consolidating multiple facilities into one global arrangement, and it adds covenants on leverage and fixed charge coverage.
Facility: $75.0 million revolving credit line and $14.0 million term loan, maturing August 25, 2031
At closing, the company borrowed $14.0 million under the term loan and had $23.0 million outstanding under the revolver
Replaced the existing credit agreement, with proceeds and other cash used to repay its borrowings in full
Requires a leverage ratio of no more than 3.00 to 1.00 and a fixed charge coverage ratio of at least 1.25 to 1.00
Core Scientific entered into a credit agreement on August 25, 2026, providing a $100 million revolving credit facility and a $500 million letter of credit facility, with no amounts outstanding at closing. The company said the facilities are expected to release about $300 million of restricted cash, which management says will improve capital efficiency and financial flexibility. The agreement is secured by substantially all company assets and carries covenants limiting debt, liens, dividends and share repurchases.
Credit agreement dated August 25, 2026, with JPMorgan Chase Bank, N.A. as administrative agent and collateral agent
$100 million revolving facility matures in three years, or four at the company's election; $500 million letter of credit facility
Revolver borrowings priced at Adjusted Term SOFR plus 1.75% or alternate base rate plus 0.75%; no amounts outstanding at closing
Company expects the facilities to release approximately $300 million of restricted cash, per CFO Jim Nygaard
On August 26, 2026, Jupiter Neurosciences' chairman and CEO, president and COO, chief scientific officer, and chief administrative officer irrevocably forgave $875,315 of accrued, unpaid compensation owed to them by the company. The filing says the forgiveness was gratuitous, with no equity issued and no cash or other consideration paid, so the change removes liabilities from the balance sheet without a cash outlay.
Total forgiven: $875,315 of accrued salaries reflected as liabilities on the balance sheet
Christer Rosén (Chairman and CEO and Director) forgave $356,024; Marshall Hayward, Ph.D. (Chief Scientific Officer and Director) forgave $287,075
Alison Silva (President, COO and Director) forgave $81,431; Alexander Rosén (Chief Administrative Officer) forgave $150,785
Effective August 26, 2026; the company issued no equity or cash in exchange, and each agreement includes a general release of related claims
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.